3区 · 生物学
ArticleOA
作者: Cui, Long-Hui ; Park, Ji-Na ; Kim, Hyo Jin ; Ko, Tae Hee ; Kim, Dong-Hyung ; Song, Myeong-Hwa ; Jang, Yongjun ; Noh, Ji-Min ; Hong, Soon Jun ; Paek, Se-Hwan ; Kim, Kyung-Seob ; Joo, Hyung Joon ; Lim, Do-Sun ; Seo, Ha-Rim ; Choi, Seung-Cheol ; Park, Chi-Yeon ; Kim, Jong-Ho ; Kim, Jong-Hoon ; Choi, Ji-Hyun ; Choi, Jong-Il ; Park, Yongdoo
Mature cardiomyocytes (CMs) obtained from human pluripotent stem cells (hPSCs) have been required for more accurate in vitro modeling of adult-onset cardiac disease and drug discovery. Here, we found that FGF4 and ascorbic acid (AA) induce differentiation of BG01 human embryonic stem cell–cardiogenic mesoderm cells (hESC-CMCs) into mature and ventricular CMs. Co-treatment of BG01 hESC-CMCs with FGF4+AA synergistically induced differentiation into mature and ventricular CMs. FGF4+AA-treated BG01 hESC-CMs robustly released acute myocardial infarction (AMI) biomarkers (cTnI, CK-MB, and myoglobin) into culture medium in response to hypoxic injury. Hypoxia-responsive genes and potential cardiac biomarkers proved in the diagnosis and prognosis of coronary artery diseases were induced in FGF4+AA-treated BG01 hESC-CMs in response to hypoxia based on transcriptome analyses. This study demonstrates that it is feasible to model hypoxic stress in vitro using hESC-CMs matured by soluble factors.